scholarly journals Dual HER2 blockade therapy increases the risk of developing cardiac toxicities in HER2‐positive breast cancer: An up‐to‐date comprehensive meta‐analysis

2020 ◽  
Author(s):  
Wei‐Xiang Qi ◽  
Lu Cao ◽  
Cheng Xu ◽  
Shengguang Zhao ◽  
Jiayi Chen
Keyword(s):  
Breast Cancer ◽  
Meta Analysis ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

scholarly journals Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

2021 ◽  
Vol 22 (8) ◽  
pp. 1139-1150
Author(s):  
Rosie Bradley ◽  
Jeremy Braybrooke ◽  
Richard Gray ◽  
Robert Hills ◽  
Zulian Liu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Stage ◽  
Meta Analysis ◽  
Randomised Trials ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

scholarly journals HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis

2020 ◽  
Vol 84 ◽  
pp. 101965 ◽  
Author(s):  
Francesco Schettini ◽  
Tomás Pascual ◽  
Benedetta Conte ◽  
Nuria Chic ◽  
Fara Brasó-Maristany ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Pathological Complete Response ◽  
Meta Analysis ◽  
Complete Response ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer

The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer

2018 ◽  
Vol 62 ◽  
pp. 9-17 ◽  
Author(s):  
Ayako Nakashoji ◽  
Tetsu Hayashida ◽  
Takamichi Yokoe ◽  
Hinako Maeda ◽  
Tomoka Toyota ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Therapy ◽  
Meta Analysis ◽  
Her2 Positive ◽  
Her2 Positive Breast Cancer ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document